DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 55 filers reported holding DERMA SCIENCES INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $7,000 | -46.2% | 1,000 | -33.3% | 0.01% | -37.5% |
| Q1 2015 | $13,000 | -7.1% | 1,500 | 0.0% | 0.01% | -11.1% |
| Q4 2014 | $14,000 | -17.6% | 1,500 | -25.0% | 0.01% | 0.0% |
| Q3 2014 | $17,000 | -26.1% | 2,000 | 0.0% | 0.01% | -30.8% |
| Q2 2014 | $23,000 | -8.0% | 2,000 | 0.0% | 0.01% | -18.8% |
| Q1 2014 | $25,000 | +13.6% | 2,000 | 0.0% | 0.02% | +23.1% |
| Q4 2013 | $22,000 | -12.0% | 2,000 | 0.0% | 0.01% | -13.3% |
| Q3 2013 | $25,000 | -52.8% | 2,000 | -50.0% | 0.02% | -59.5% |
| Q2 2013 | $53,000 | – | 4,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |